Immune cell-mediated inflammation and the early improvements in glucose metabolism after gastric banding surgery

Diabetologia

Volumn 56, Issue 12, 2013, Pages 2564-2572

  Samaras, Katherine ^a,b   Viardot, Alexander ^a   Botelho, Natalia K ^c   Jenkins, Alicia ^d   Lord, Reginald V ^c,e  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

^e Notre Dame School of Medicine   (Australia)

Author keywords

Adipokine; Bariatric surgery; Diabetes; Glucose; Immune cells; Inflammation; Insulin resistance; Lymphocyte; Obesity; Tumour necrosis factor ; Weight loss

Indexed keywords

GLUCOSE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CELL ACTIVATION; CELL COUNT; CELLULAR IMMUNITY; DIABETES MELLITUS; GASTRIC BANDING; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GRANULOCYTE; HUMAN; IMMUNOCOMPETENT CELL; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RELEASE; INSULIN SENSITIVITY; LYMPHOCYTE COUNT; OBESITY; PRIORITY JOURNAL;

ADAPTIVE IMMUNITY; ADIPOKINES; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GASTROPLASTY; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFLAMMATION; LAPAROSCOPY; MACROPHAGES; MALE; MIDDLE AGED; OBESITY, MORBID; REMISSION INDUCTION; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84887907086     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-3033-7     Document Type: Article

References (47)

1. Adams TD, Davidson LE, Litwin SE et al (2012) Health benefits of gastric bypass surgery after 6 years. J Am Med Assoc 308:1122-1131
2. Adams TD, Gress RE, Smith SC et al (2007) Long-term mortality after gastric bypass surgery. N Engl J Med 357:753-761
3. Adams TD, Pendleton RC, Strong MB et al (2010) Health outcomes of gastric bypass patients compared to nonsurgical, nonintervened severely obese. Obesity (Silver Spring) 18:121-130
4. Iaconelli A, Panunzi S, de Gaetano A et al (2011) Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up. Diabetes Care 34:561-567
5. Lee WJ, Hur KY, Lakadawala M, Kasama K, Wong SK, Lee YC (2012) Gastrointestinal metabolic surgery for the treatment of diabetic patients: a multi-institutional international study. J Gastrointest Surg 16:45-51, discussion 51-52
6. Leslie DB, Dorman RB, Serrot FJ et al (2012) Efficacy of the Roux-en-Y gastric bypass compared to medically managed controls in meeting the American Diabetes Association composite end point goals for management of type 2 diabetes mellitus. Obes Surg 22:367-374
7. Pontiroli AE, Folli F, Paganelli M et al (2005) Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: a 4-year case-controlled study. Diabetes Care 28:2703-2709
8. Scopinaro N, Adami GF, Papadia FS et al (2011) The effects of biliopancreatic diversion on type 2 diabetes mellitus in patients with mild obesity (BMI 30-35 kg/m2) and simple overweight (BMI 25-30 kg/m2): a prospective controlled study. Obes Surg 21:880-888
9. Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L (2004) XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 27:155-161
10. Sjostrom L, Narbro K, Sjostrom CD et al (2007) Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357:741-752
11. Schauer PR, Kashyap SR, Wolski K et al (2012) Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 366:1567-1576
12. Dixon JB, O'Brien PE, Playfair J et al (2008) Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. J Am Med Assoc 299:316-323
13. Mingrone G, Panunzi S, de Gaetano A et al (2012) Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 366:1577-1585
14. Lee WJ, Chong K, Ser KH et al (2011) Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg 146:143-148
15. Pinheiro JS, Schiavon CA, Pereira PB, Correa JL, Noujaim P, Cohen R (2008) Long-long limb Roux-en-Y gastric bypass is more efficacious in treatment of type 2 diabetes and lipid disorders in super-obese patients. Surg Obes Relat Dis 4:521-525
16. Ikonomidis I, Mazarakis A, Papadopoulos C et al (2007) Weight loss after bariatric surgery improves aortic elastic properties and left ventricular function in individuals with morbid obesity: a 3-year follow-up study. J Hypertension 25:439-447
17. Rider OJ, Francis JM, Ali MK et al (2009) Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity. J Am Coll Cardiol 54:718-726
18. Samaras K, Viardot A, Lee PN et al (2013) Reduced arterial stiffness after weight loss in obese type 2 diabetes and impaired glucose tolerance: the role of immune cell activation and insulin resistance. Diab Vasc Dis Res 10:40-48
19. Shargorodsky M, Fleed A, Boaz M, Gavish D, Zimlichman R (2006) The effect of a rapid weight loss induced by laparoscopic adjustable gastric banding on arterial stiffness, metabolic and inflammatory parameters in patients with morbid obesity. Int J Obes (Lond) 30:1632-1638
20. Samaras K (2013) Bariatric surgery for type 2 diabetes: to whom and when? Minerva Endocrinol 38:47-58
21. Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98-107
22. Swarbrick MM, Stanhope KL, Austrheim-Smith IT et al (2008) Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery. Diabetologia 51:1901-1911
23. Trakhtenbroit MA, Leichman JG, Algahim MF et al (2009) Body weight, insulin resistance, and serum adipokine levels 2 years after 2 types of bariatric surgery. Am J Med 122:435-442
24. Illan-Gomez F, Gonzalvez-Ortega M, Orea-Soler I et al (2012) Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery. Obes Surg 22:950-955
25. Mather KJ, Funahashi T, Matsuzawa Y et al (2008) Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program. Diabetes 57:980-986
26. Spranger J, Kroke A, Mohlig M et al (2003) Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52:812-817
27. Viardot A, Heilbronn LK, Samocha-Bonet D, Mackay F, Campbell LV, Samaras K (2012) Obesity is associated with activated and insulin resistant immune cells. Diabetes Metab Res Rev 28:447-454
28. Viardot A, Lord RV, Samaras K (2010) The effects of weight loss and gastric banding on the innate and adaptive immune system in type 2 diabetes and prediabetes. J Clin Endocrinol Metab 95:2845-2850
29. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539-548
30. Seltzer HS, Allen EW, Herron AL Jr, Brennan MT (1967) Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest 46:323-335
31. Taylor R (2013) Banting Memorial Lecture 2012. Reversing the twin cycles of type 2 diabetes. Diabet Med 30:267-275
32. Matarese G, Procaccini C, de Rosa V (2012) At the crossroad of T cells, adipose tissue, and diabetes. Immunol Rev 249:116-134
33. Schauer PR, Burguera B, Ikramuddin S et al (2003) Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Annals Surg 238:467-484
34. Guidone C, Manco M, Valera-Mora E et al (2006) Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 55:2025-2031
35. Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R (2011) Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 54:2506-2514
36. Kintscher U, Hartge M, Hess K et al (2008) T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 28:1304-1310
37. Nishimura S, Manabe I, Nagasaki M et al (2009) CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nature Med 15:914-920
38. Procaccini C, de Rosa V, Galgani M et al (2010) An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity 33:929-941
39. Cottam DR, Schaefer PA, Shaftan GW, Angus LD (2003) Dysfunctional immune-privilege in morbid obesity: implications and effect of gastric bypass surgery. Obes Surg 13:49-57
40. Fraser DA, Thoen J, Reseland JE, Forre O, Kjeldsen-Kragh J (1999) Decreased CD4+ lymphocyte activation and increased interleukin-4 production in peripheral blood of rheumatoid arthritis patients after acute starvation. Clin Rheumatol 18:394-401
41. Hirsch FF, Pareja JC, Geloneze SR, Chaim E, Cazzo E, Geloneze B (2012) Comparison of metabolic effects of surgical-induced massive weight loss in patients with long-term remission versus non-remission of type 2 diabetes. Obes Surg 22:910-917
42. Brethauer SA, Heneghan HM, Eldar S et al (2011) Early effects of gastric bypass on endothelial function, inflammation, and cardiovascular risk in obese patients. Surg Endoscopy 25:2650-2659
43. Marantos G, Daskalakis M, Karkavitsas N, Matalliotakis I, Papadakis JA, Melissas J (2011) Changes in metabolic profile and adipoinsular axis in morbidly obese premenopausal females treated with restrictive bariatric surgery. World J Surg 35:2022-2030
44. Miller GD, Nicklas BJ, Fernandez A (2011) Serial changes in inflammatory biomarkers after Roux-en-Y gastric bypass surgery. Surg Obesity Rel Dis 7:618-624
45. Kopp HP, Kopp CW, Festa A et al (2003) Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol 23:1042-1047
46. Moschen AR, Molnar C, Geiger S et al (2010) Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression. Gut 59:1259-1264
47. Isbell JM, Tamboli RA, Hansen EN et al (2010) The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care 33:1438-1442